|
1
|
Gerard IE and Karen HV: Proliferation,
cell cycle and apoptosis in cancer. Nature. 411:342–348. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mcconkey BJ, Bold RJ and Termuhlen PM:
Apoptosis, cancer and cancer therapy. Surg Oncol. 6:133–142. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ma C, Liu Y, Zheng J, Fang W, You J, Wang
J, Cui X and Wu B: Identification of tumor metastasisrelated gene
TMSG-1 by mRNA differential display. Sci China C Life Sci.
45:553–560. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pan H, Qin WX, Huo KK, Wan DF, Yu Y, Xu
ZG, Hu QD, Gu KT, Zhou XM, Jiang HQ, et al: Cloning, mapping, and
characterization of a human homologue of the yeast longevity
assurance gene LAG1. Genomics. 77:58–64. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xu XY, Pei F and You JF: TMSG-1 and its
roles in tumor biology. Chin J Cancer. 29:697–702. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yu W, Wang L, Wang Y, Xu X, Zou P, Gong M,
Zheng J, You J, Wang H, Mei F and Pei F: A novel tumor metastasis
suppressor gene LASS2/TMSG1 interacts with vacuolar ATPase through
its homeodomain. J Cell Biochem. 114:570–583. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Teufel A, Maass T, Galle PR and Malik N:
The longevity assurance homologue of yeast lag1 (Lass) gene family
(review). Int J Mol Med. 23:135–140. 2009.PubMed/NCBI
|
|
9
|
Xu X, You J and Pei F: LASS2/TMSG1 gene
silencing promotes the invasiveness and metastatic of human
prostatic carcinoma cells through increase in vacuolar ATPase
activity. Zhonghua Bing Li Xue Za Zhi. 43:177–183. 2014.(In
Chinese). PubMed/NCBI
|
|
10
|
Fan S, Niu Y, Tan N, Wu Z, Wang Y, You H,
Ke R, Song J, Shen Q, Wang W, et al: LASS2 enhances
chemosensitivity of breast cancer by counteracting acidic tumor
microenvironment through inhibiting activity of V-ATPase proton
pump. Oncogene. 32:1682–1690. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen L, Lu X, Zeng T, Chen Y, Chen Q, Wu
W, Yan X, Cai H, Zhang Z, Shao Q and Qin W: Enhancement of
DEN-induced liver tumourigenesis in hepatocyte-specific
Lass2-knockout mice coincident with upregulation of the
TGF-β1-Smad4-PAI-1 axis. Oncol Rep. 31:885–893. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang B: Expression and clinical
significance of TMSG1 in gastric cancer. China Practical Medicine.
8:1–2. 2013.
|
|
13
|
Yang Y, Yang X, Li L, Yang G, Ouyang X,
Xiang J, Zhang T and Min X: LASS2 inhibits proliferation and
induces apoptosis in HepG2 cells by affecting mitochondrial
dynamics, the cell cycle and the nuclear factor-κB pathways. Oncol
Rep. 41:3005–3014. 2019.PubMed/NCBI
|
|
14
|
Tingqi Z, Shirong L and Jingyuan W:
Expression of LASS2/TMSG1 in non small cell lung cancer and its
clinical significance. J Clin Exp Pathol. 36:323–325. 2020.
|
|
15
|
Haiqin X, Shirong L, Lixin W, Jingyuan W,
Hai L and Xiaoyan X: Expression and significance of LASS2/TMSG-1 in
human lung cancer cell lines with different metastatic
potentiality. Journal of Shanxi Medical University. 047:884–889.
2016.
|
|
16
|
Xu Haiqin LS, Weng Lixin, Wang Jingyuan,
Hai Ling and Xu Xiaoyan: Expression and significance of LASS2
/TMSG-1 in human lung cancer cell lines with different metastatic
potentiality. J Shanxi Med Univ. 47:884–889. 2016.
|
|
17
|
Chen SH, Bubb MR, Yarmola EG, Zuo J, Jiang
J, Lee BS, Lu M, Gluck SL, Hurst IR and Holliday LS: Vacuolar
H+-ATPase binding to microfilaments: Regulation in response to
phosphatidylinositol 3-kinase activity and detailed
characterization of the actin-binding site in subunit B. J Biol
Chem. 279:7988–7998. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Su J, You J, Zhen J, Cui X and Fang W:
Studies of tumor metastasis suppressor gene TMSG-1 inhibited
proliferation and invasion of prostate cancer cell line PC-3M-1E8
in vitro. Zhonghua Zhong Liu Za Zhi. 30:404–407. 2008.(In Chinese).
PubMed/NCBI
|
|
19
|
Tang N, You H, Jin J, Yu B and Qin W:
Small interfering RNA targeting LASS2 gene enhances invasion
capacity of hepatocellular carcinoma cells. Tumor. 29:399–403.
2009.
|
|
20
|
Mehlen P and Puisieux A: Metastasis: A
question of life or death. Nat Rev Cancer. 6:449–458. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wong NC, Mueller BM, Barbas CF, Ruminski
P, Quaranta V, Lin EC and Smith JW: Alphav integrins mediate
adhesion and migration of breast carcinoma cell lines. Clin Exp
Metastasis. 16:50–61. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Townson JL, Naumov GN and Chambers AF: The
role of apoptosis in tumor progression and metastasis. Curr Mol
Med. 3:631–642. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Márquez-Jurado S, Díaz-Colunga J, das
Neves RP, Martinez-Lorente A, Almazán F, Guantes R and Iborra FJ:
Mitochondrial levels determine variability in cell death by
modulating apoptotic gene expression. Nat Commun. 9:3892018.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zou P, Yang Y, Xu X, Liu B, Mei F, You J,
Liu Q and Pei F: Silencing of vacuolar ATPase c subunit ATP6V0C
inhibits the invasion of prostate cancer cells through a
LASS2/TMSG1-independent manner. Oncol Rep. 39:298–306.
2018.PubMed/NCBI
|
|
25
|
Wang H, Zuo Y, Ding M, Ke C, Yan R, Zhan
H, Liu J, Wang W, Li N and Wang J: LASS2 inhibits growth and
invasion of bladder cancer by regulating ATPase activity. Oncol
Lett. 13:661–668. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xu X YR, Li X, Yu H and Li S: Effect of
LASS2/TMSG-1 overexpression on the invasion and migration of 95D
human pulmonary carcinoma cell and its mechanism. Chinese Journal
of Clinical and Experimental Pathology. 32:901–907. 2016.
|
|
27
|
Zuo H LX, Li S, Yun F and Xu X: Effect of
LASS2/TMSG on the invation and migration of 95C human pulmonary
carcinoma cell. Chinese Journal of Cancer Prevention and Treatment.
22:1865–1873. 2015.
|
|
28
|
Zeng F, Huang L, Cheng X, Yang X, Li T,
Feng G, Tang Y and Yang Y: Overexpression of LASS2 inhibits
proliferation and causes G0/G1 cell cycle arrest in papillary
thyroid cancer. Cancer Cell Int. 18:1512018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Beyenbach KW and Wieczorek H: The V-type
H+ ATPase: Molecular structure and function, physiological roles
and regulation. J Exp Biol. 209:577–589. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
De Milito A, Canese R, Marino ML, Borghi
M, Iero M, Villa A, Venturi G, Lozupone F, Iessi E, Logozzi M, et
al: pH-dependent antitumor activity of proton pump inhibitors
against human melanoma is mediated by inhibition of tumor acidity.
Int J Cancer. 127:207–219. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kumar S, Kasseckert S, Kostin S, Abdallah
Y, Schafer C, Kaminski A, Reusch HP, Piper HM, Steinhoff G and
Ladilov Y: Ischemic acidosis causes apoptosis in coronary
endothelial cells through activation of caspase-12. Cardiovasc Res.
73:172–180. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yang T, Li MH, Liu J, Huang N, Li N, Liu
SN, Liu Y, Zhang T, Zou Q and Li H: Benzimidazole derivative,
BMT-1, induces apoptosis in multiple myeloma cells via a
mitochondrial-mediated pathway involving H+/K+-ATPase inhibition.
Oncol Rep. 31:2743–2750. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bock FJ and Tait SW: Mitochondria as
multifaceted regulators of cell death. Nat Rev Mol Cell Biol.
21:85–100. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen M and Wang J: Initiator caspases in
apoptosis signaling pathways. Apoptosis. 7:313–319. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Rosse T, Olivier R, Monney L, Rager M,
Conus S, Fellay I, Jansen B and Borner C: Bcl-2 prolongs cell
survival after Bax-induced release of cytochrome c. Nature.
391:496–499. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Oltvai ZN, Milliman CL and Korsmeyer SJ:
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that
accelerates programmed cell death. Cell. 74:609–619. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Huang S, He P, Xu D, Li J, Peng X and Tang
Y: Acidic stress induces apoptosis and inhibits angiogenesis in
human bone marrow-derived endothelial progenitor cells. Oncol Lett.
14:5695–5702. 2017.PubMed/NCBI
|
|
38
|
Sasazawa Y, Futamura Y, Tashiro E and
Imoto M: Vacuolar H+-ATPase inhibitors overcome Bcl-xL-mediated
chemoresistance through restoration of a caspase-independent
apoptotic pathway. Cancer Sci. 100:1460–1467. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Pérez-Pérez A, Toro A, Vilariño-Garcia T,
Guadix P, Maymó J, Dueñas JL, Varone C and Sánchez-Margalet V:
Leptin protects placental cells from apoptosis induced by acidic
stress. Cell Tissue Res. 375:733–742. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Fujiwara M, Tian L, Le PT, DeMambro VE,
Becker KA, Rosen CJ and Guntur AR: The mitophagy receptor
Bcl-2-like protein 13 stimulates adipogenesis by regulating
mitochondrial oxidative phosphorylation and apoptosis in mice. J
Biol Chem. 294:12683–12694. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Edlich F: BCL-2 proteins and apoptosis:
Recent insights and unknowns. Biochem Biophy Res Commun. 500:26–34.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wallberg F, Tenev T and Meier P: Analysis
of apoptosis and necroptosis by fluorescence-activated cell
sorting. Cold Spring Harbor Protoc 1. pdb.prot087387. 2016.
View Article : Google Scholar : PubMed/NCBI
|
